In vitro and in vivo anthelmintic activity of (-)-6,6'-dinitrohinokinin against schistosomula and juvenile and adult worms of Schistosoma mansoni

Acta Tropica

Volumn 149, Issue , 2015, Pages 195-201

  Pereira, Ana C ^a,c   e Silva, Márcio L A e ^a   Souza, Julia Medeiros ^a   de Laurentiz, Rosangela S ^b   Rodrigues, Vanderlei ^c   Januário, Ana H ^a   Pauletti, Patrícia M ^a   Tavares, Denise C ^a   Filho, Ademar A Da Silva ^d   Cunha, Wilson R ^a   Bastos, Jairo K ^c   Magalhães, Lizandra G ^a  

^a UNIVERSIDADE DE FRANCA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

( ) 6,6' Dinitrohinokinin; Lignan; Schistosoma mansoni

Indexed keywords

6,6' DINITROHINOKININ; ANTHELMINTIC AGENT; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 6,6'-DINITROHINOKININ; GAMMA BUTYROLACTONE; LIGNAN;

BIOACCUMULATION; CHEMOTHERAPY; ENZYME ACTIVITY; SCANNING ELECTRON MICROSCOPY; SCHISTOSOMIASIS;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ARTICLE; CHINESE HAMSTER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFICACY; EGG PRODUCTION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTEGUMENT; JUVENILE ANIMAL; LC50; LIVER WEIGHT; LUNG FIBROBLAST; MOUSE; NONHUMAN; OOCYTE DEVELOPMENT; SCANNING ELECTRON MICROSCOPY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMULUM; SPLEEN WEIGHT; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CRICETULUS; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; HAMSTER; LIVER; LUNG; PARASITOLOGY; ULTRASTRUCTURE;

CRICETULUS GRISEUS; MUS; SCHISTOSOMA MANSONI;

4-BUTYROLACTONE; ANIMALS; ANTHELMINTICS; BENZODIOXOLES; CRICETINAE; CRICETULUS; FEMALE; FIBROBLASTS; IN VITRO TECHNIQUES; LIGNANS; LIVER; LUNG; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 84934897132     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2015.06.005     Document Type: Article

References (43)

1. Abdulla M.H., Lim K.C., Sajid M., McKerrow J.H., Caffrey C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. Plos Med. 2007, 4:e14.
2. Apers S., Vlietinck A., Pieters L. Lignans and neolignans as lead compounds. Phytochem. Rev. 2003, 2:201-217.
3. Aires A.L., Ximenes E.C., Barbosa V.X., Góes A.J., Souza V.M., Albuquerque M.C. ó-Lapachone: a naphthoquinone with promising antischistosomal properties in mice. Phytomedicine 2014, 21(3):261-267.
4. Cheever A.W. Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull. World Health Organ. 1968, 39:328-331.
5. Da Silva R., De Souza G.H., Da Silva A.A., De Souza V.A., Pereira A.C., Royo V.A., De Silva M.L.A., Donate P.M., De Matos Araújo A.L., Carvalho J.C., Bastos J.K. Synthesis and biological activity evaluation of lignan lactones derived from (-)-cubebin. Bioorg. Med. Chem. Lett. 2005, 15(4):1033-1037.
6. De Melo N.I., Magalhães L.G., De Carvalho C.E., Wakabayashi K.A., De Paula Aguiar G., Ramos R.C., Mantovani A.L., Turatti I.C., Rodrigues V., Groppo M., Cunha W.R., Veneziani R.C., Crotti A.E. Schistosomicidal activity of the essential oil of Ageratum conyzoides L (Asteraceae) against adult Schistosoma mansoni worms. Molecules 2011, 16:762-773.
7. Esperandim V.R., Da Silva Ferreira D., Saraiva J., Silva M.L., Costa E.S., Pereira A.C., Bastos J.K., De Albuquerque S. Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitol. Res. 2010, 107:525-530.
8. Fallon P.G., Doenhoff M.J. Drug-resistant schistosomiasis, resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 1994, 51:83-88.
9. Freitas T.C., Jung E., Pearce E.J. TGF-β Signaling controls embryo development in the parasitic flatworm Schistosoma mansoni. PLoS Pathog. 2007, 3:489-497.
10. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
11. Harrop R., Wilson R.A. Protein synthesis and release by culture of schistosomula of Schistosoma mansoni. Parasitology 1993, 103:265-274.
12. Holtfreter M.C., Loebermann M., Klammt S., Sombetzki M., Bodammer P., Riebold D., Kinzelbach R., Reisinger E.C. Schistosoma mansoni, schistosomicidal effect of mefloquine and primaquine in vitro. Exp. Parasitol. 2011, 127:270-276.
13. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Sachs S.E., Sachs J.D., Savioli L. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
14. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., Bennett J.L. Resistance to praziquantel, direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 1999, 6:932-935.
15. Kunz W. Schistosome male-female interaction, induction of germ-cell differentiation. Trends Parasitol. 2001, 17:227-231.
16. Lenta B.N., Vonthron-Sénécheau C.R., Sohd F., Tantangmo F., Ngouela S., Kaiser M., Tsamo E., Anton R., Weniger B. In vitro antiprotozoal activities and cytotoxicity of some selected of some selected Cameroonian medicinal plants. J. Ethnopharmacol. 2007, 111:8-12.
17. Magalhães L.G., De Souza J.M., Wakabayashi K.A., Laurentiz R.S., Vinhólis A.H., Rezende K.C., Simaro G.V., Bastos J.K., Rodrigues V., Esperandim V.R., Ferreira D.S., Crotti A.E., Cunha W.R., Silva M.L. In vitro efficacy of the essential oil of Piper cubeba L (Piperaceae) against Schistosoma mansoni. Parasitol. Res. 2012, 110:1747-1754.
18. Manneck T., Haggenmüller Y., Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 2010, 137:85-98.
19. Menezes C.M., Rivera G., Alves M.A., Do Amaral D.N., Thibaut J.P., Noël F., Barreiro E.J., Lima L.M. Synthesis, biological evaluation, and structure-activity relationship of clonazepam, meclonazepam, and. 1,4-benzodiazepine compounds with schistosomicidal activity. Chem. Biol. Drug. Des. 2012, 79(6):943-949.
20. Moraes J., Nascimento C., Lopes P.O., Nakano E., Yamaguchi L.F., Kato M.J., Kawano T. Schistosoma mansoni: in vitro schistosomicidal activity of piplartine. Exp. Parasitol. 2011, 127:357-364.
21. Michaels R.M., Prata A. Evolution and characteristics of Schistosoma mansoni eggs laid in vitro. J. Parasitol. 1968, 54:921-930.
22. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75:311-335.
23. Paula F.R., Serrano S.H.P., Tavares L.C. Aspectos mecanísticos da bioatividade e toxicidade de nitrocompostos. Quim. Nova 2009, 32:1013-1020.
24. Pica-Mattoccia L., Cioli D. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int. J. Parasitol. 2004, 34:527-533.
25. Radke M.G., Broome P.B., Belanger G.S. Schistosoma mansoni, mouse mortality test system for mass screening for prophylactic drugs. Exp. Parasitol. 1971, 30:1-10.
26. Ramirez B., Bickle Q., Yousif F., Fakorede F., Mouries M.A., Nwaka S. Schistosomes: challenges in drug screening. Exp. Opin. Drug Dis. 2007, 2:53-61.
27. Resende F.A., Tomazella I.M., Barbosa L.C., Ponce M., Furtado R.A., Pereira N.A., Bastos J.K., Silva M.L.A., Tavares D.C. Effect of the dibenzylbutyrolactone lignan (-)-hinokinin on doxorubicin and methyl methanesulfonate clastogenicity in V79Chinese hamster lung fibroblasts. Mut. Res. 2010, 700:62-66.
28. Ribeiro-dos-Santos G., Verjovski-Almeida S., Leite L.C. Schistosomiasis-a century searching for chemotherapeutic drugs. Parasitol. Res. 2006, 99:505-521.
29. Rollinson D., Knopp S., Levitz S., Stothard J.R., Tchuenté L.A., Garba A., Mohammed K.A., Schur N., Person B., Colley D.G., Utzinger J. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013, 128(2):423-440.
30. Royo V.A., Santos F.F., Souza V.A., Pereira A.C., Da Silva R., Vinhólis A.H.C., Donate P.M., Silva M.L.A., Albuquerque S., Bastos J.K. Biological activity evaluation of dibenzylbutyrolactone lignans derivatives against Leishmania braziliensis. Braz. J. Pharmacogn. 2003, 13:18-21.
31. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol. 1986, 61:294-303.
32. Sanderson L., Bartlett A., Whitfield P.J. In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract toward adult schistosomes and their egg production. J. Helminthol. 2002, 76:241-247.
33. Saraiva J., Veja C., Rolon M., Da Silva R., Silva M.L., Donate P.M., Bastos J.K., Gomez-Barrio A., De Albuquerque S. In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi. Parasitol. Res. 2007, 100:791-795.
34. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 2008, 14:407-412.
35. Shuhua X., Binggui S., Chollet J., Tanner M. Tegumental changes in adult Schistosoma mansoni harboured in mice treated with praziquantel enantiomers. Acta Trop. 2000, 76:107-117.
36. Silva R., Souza H.B., Silva A.A., Souza V.A., Pereira A.C., Royo V.A., Silva M.L.A. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg. Med. Chem. Lett. 2005, 15:303-307.
37. Silva M.L., Coímbra H.S., Pereira A.C., Almeida V.A., Lima T.C., Costa E.S., Vinhólis A.H., Royo V.A., Silva R., Filho A.A., Cunha W.R., Furtado N.A., Martins C.H., Carvalho T.C., Bastos J.K. Evaluation of Piper cubeba extract (-)-cubebin and its semi-synthetic derivatives against oral pathogens. Phytother. Res. 2007, 21:420-422.
38. Smithers S.R., Terry R.J. Infection of Laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adult worms. Parasitololgy 1965, 55:695-700.
39. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development, systematic review meta-analysis and estimates of people at risk. Lancet Infect. Dis. 2009, 6:411-425.
40. Usia T., Watabe T., Kadota S., Tezuka Y. Potent CYP3A4 inhibitory constituents of Piper cubeba. J. Nat. Prod. 2005, 68:64-68.
41. Van der Werf M.J., De Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003, 86:125-139.
42. Xiao S.H., Keiser J., Chollet J., Utzinger J., Dong Y., Endriss Y., Vennerstrom J.L., Tanner M. In vitro and in vivo activities of synthetic trioxolanes against major human Schistosome species. Antimicrob. Agents. Chemother. 2007, 51:1440-1445.
43. Wang W.L., Song L.J., Chen X., Yin X.R., Fan W.H., Wang G.P., Yu C.X., Feng B. Synthesis and SAR studies of praziquantel derivatives with activity against Schistosoma japonicum. Molecules 2013, 18(8):9163-9178.